Trough Lopinavir Concentrations in Preterm HIV-infected Infants

The Pediatric Infectious Disease Journal, 06/01/2012

Because of serious adverse effects, the Food and Drug Administration warns against using lopinavir in infants younger than 42 weeks postconception. However, there is an imperative for early treatment.

Print Article Summary Cat 2 CME Report